Independent Psoriasis Registry to Track Safety of Recently Approved Treatment Taltz (Ixekizumab)
News
The Portland, Oregon-based Corrona Psoriasis Registry announced it has been selected to track drug safety reporting for ixekizumab, a new biologic medication developed by global pharma Eli Lilly of Indianapolis, which markets ... Read more